<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>148</number>
    <updateDate>2025-07-21T19:32:26Z</updateDate>
    <updateDateIncludingText>2025-07-21T19:32:26Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2023-01-30</introducedDate>
    <congress>118</congress>
    <committees>
      <item>
        <systemCode>ssju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Reported By</name>
            <date>2023-03-01T21:19:19Z</date>
          </item>
          <item>
            <name>Markup By</name>
            <date>2023-02-09T17:53:21Z</date>
          </item>
          <item>
            <name>Referred To</name>
            <date>2023-01-30T23:09:37Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2023-03-01</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 21.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2023-03-01</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-03-01</actionDate>
        <text>Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.</text>
        <type>Committee</type>
        <actionCode>14000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-02-09</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-01-30</actionDate>
        <committees>
          <item>
            <systemCode>ssju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on the Judiciary.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2023-01-30</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>K000367</bioguideId>
        <fullName>Sen. Klobuchar, Amy [D-MN]</fullName>
        <firstName>Amy</firstName>
        <lastName>Klobuchar</lastName>
        <party>D</party>
        <state>MN</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>G000386</bioguideId>
        <fullName>Sen. Grassley, Chuck [R-IA]</fullName>
        <firstName>Chuck</firstName>
        <lastName>Grassley</lastName>
        <party>R</party>
        <state>IA</state>
        <sponsorshipDate>2023-01-30</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000563</bioguideId>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <firstName>Richard</firstName>
        <lastName>Durbin</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>J.</middleName>
        <sponsorshipDate>2023-01-30</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001310</bioguideId>
        <fullName>Sen. Braun, Mike [R-IN]</fullName>
        <firstName>Mike</firstName>
        <lastName>Braun</lastName>
        <party>R</party>
        <state>IN</state>
        <sponsorshipDate>2023-01-30</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001277</bioguideId>
        <fullName>Sen. Blumenthal, Richard [D-CT]</fullName>
        <firstName>Richard</firstName>
        <lastName>Blumenthal</lastName>
        <party>D</party>
        <state>CT</state>
        <sponsorshipDate>2023-01-30</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001098</bioguideId>
        <fullName>Sen. Cruz, Ted [R-TX]</fullName>
        <firstName>Ted</firstName>
        <lastName>Cruz</lastName>
        <party>R</party>
        <state>TX</state>
        <sponsorshipDate>2023-01-30</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001288</bioguideId>
        <fullName>Sen. Booker, Cory A. [D-NJ]</fullName>
        <firstName>Cory</firstName>
        <lastName>Booker</lastName>
        <party>D</party>
        <state>NJ</state>
        <sponsorshipDate>2023-01-30</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>O000174</bioguideId>
        <fullName>Sen. Ossoff, Jon [D-GA]</fullName>
        <firstName>Jon</firstName>
        <lastName>Ossoff</lastName>
        <party>D</party>
        <state>GA</state>
        <sponsorshipDate>2023-02-01</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000800</bioguideId>
        <fullName>Sen. Welch, Peter [D-VT]</fullName>
        <firstName>Peter</firstName>
        <lastName>Welch</lastName>
        <party>D</party>
        <state>VT</state>
        <sponsorshipDate>2023-02-09</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2024-03-13T15:24:00Z</pubDate>
        <title>S. 148, Stop STALLING Act</title>
        <url>https://www.cbo.gov/publication/60084</url>
        <description>As reported by the Senate Committee on the Judiciary on March 1, 2023</description>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative remedies</name>
          <updateDate>2023-03-01T19:30:26Z</updateDate>
        </item>
        <item>
          <name>Business ethics</name>
          <updateDate>2023-03-01T19:30:26Z</updateDate>
        </item>
        <item>
          <name>Civil actions and liability</name>
          <updateDate>2023-03-01T19:30:26Z</updateDate>
        </item>
        <item>
          <name>Competition and antitrust</name>
          <updateDate>2023-03-01T19:30:26Z</updateDate>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
          <updateDate>2023-03-01T19:30:26Z</updateDate>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
          <updateDate>2023-03-01T19:30:26Z</updateDate>
        </item>
        <item>
          <name>Food and Drug Administration (FDA)</name>
          <updateDate>2023-03-01T19:30:26Z</updateDate>
        </item>
        <item>
          <name>Licensing and registrations</name>
          <updateDate>2023-03-01T19:30:26Z</updateDate>
        </item>
        <item>
          <name>Prescription drugs</name>
          <updateDate>2023-03-01T19:30:26Z</updateDate>
        </item>
        <item>
          <name>Public participation and lobbying</name>
          <updateDate>2023-03-01T19:30:26Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-02-14T16:30:34Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-01-30</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2023-03-06T11:57:20Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the&lt;/b&gt; &lt;b&gt;Stop STALLING Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.&lt;/p&gt; &lt;p&gt;The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.&lt;/p&gt;</text>
        </cdata>
      </summary>
      <summary>
        <versionCode>25</versionCode>
        <actionDate>2023-03-01</actionDate>
        <actionDesc>Reported to Senate</actionDesc>
        <updateDate>2023-07-18T16:53:56Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;b&gt;Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the&lt;/b&gt; &lt;b&gt;Stop STALLING Act&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug.&lt;/p&gt; &lt;p&gt;The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Stop STALLING Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Stop STALLING Act</title>
        <updateDate>2024-07-24T15:23:46Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Stop STALLING Act</title>
        <updateDate>2024-05-24T13:42:49Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act</title>
        <updateDate>2024-05-24T13:42:49Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to Senate</titleType>
        <titleTypeCode>103</titleTypeCode>
        <title>Stop STALLING Act</title>
        <updateDate>2024-05-24T13:42:28Z</updateDate>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Reported to Senate</billTextVersionName>
        <billTextVersionCode>RS</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to Senate</titleType>
        <titleTypeCode>103</titleTypeCode>
        <title>Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act</title>
        <updateDate>2024-05-24T13:42:28Z</updateDate>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
        <billTextVersionName>Reported to Senate</billTextVersionName>
        <billTextVersionCode>RS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.</title>
        <updateDate>2023-03-03T05:18:50Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Reported to Senate</type>
        <date>2023-03-01T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118s148rs/xml/BILLS-118s148rs.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in Senate</type>
        <date>2023-01-30T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118s148is/xml/BILLS-118s148is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-03-01</actionDate>
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 21.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
